Peripherally acting opioids and clinical implications for pain control
- PMID:21587328
Peripherally acting opioids and clinical implications for pain control
Abstract
Opioid receptors are widely expressed in the central and peripheral nervous system and in the non-neuronal tissues. Data from animal and human clinical studies support the involvement of peripheral opioid receptors in analgesia, especially in the presence of inflammation. Inflammation has been shown to increase the synthesis of opioid receptors in the dorsal root ganglion neurons and enhance transport and accumulation of opioid receptors in the peripheral terminals of sensory neurons. Under the influence of chemokines and adhesion molecules, opioid peptide-containing immune cells extravasate and accumulate in the injured tissues. Stress, chemokines, cytokines, and other releasing factors in inflamed tissues stimulate these granulocytes to release opioid peptides. Once secreted, opioid peptides bind to and activate peripheral opioid receptors on sensory nerve fibers and produce analgesia by decreasing the excitability of sensory nerves and/or inhibiting release of pro-inflammatory neuropeptides. Research has revealed that local application of exogenous opioid agonists produces a potent analgesic effect by activating peripheral opioid receptors in inflamed tissues. The analgesic activity occurs without activation of opioid receptors in the central nervous system (CNS), and therefore centrally mediated side effects, such as respiratory depression, mental clouding, altered consciousness, or addiction, are not associated with peripheral opioid activity. This discovery has stimulated research on developing peripherally restricted opioid agonists that lack CNS effects. In addition, it has been recognized that opioid receptors modulate inflammation, and that opioids have anti-inflammatory effects. The anti-inflammatory actions of opioids are not well known or understood. Conflicting reports on mu-opioids suggest both anti-inflammatory and pro-inflammatory effects. This article will present the basis for peripheral opioid analgesia and describe current research directed at developing novel treatments for pain with improved side effect profiles.
Similar articles
- Opioids and sensory nerves.Stein C, Zöllner C.Stein C, et al.Handb Exp Pharmacol. 2009;(194):495-518. doi: 10.1007/978-3-540-79090-7_14.Handb Exp Pharmacol. 2009.PMID:19655116Review.
- Targeting of opioid-producing leukocytes for pain control.Machelska H.Machelska H.Neuropeptides. 2007 Dec;41(6):355-63. doi: 10.1016/j.npep.2007.06.001. Epub 2007 Jul 20.Neuropeptides. 2007.PMID:17640727Review.
- Peripheral mechanisms of opioid analgesia.Stein C, Lang LJ.Stein C, et al.Curr Opin Pharmacol. 2009 Feb;9(1):3-8. doi: 10.1016/j.coph.2008.12.009. Epub 2009 Jan 20.Curr Opin Pharmacol. 2009.PMID:19157985Review.
- Controlling pain by influencing neurogenic pathways.Puehler W, Stein C.Puehler W, et al.Rheum Dis Clin North Am. 2005 Feb;31(1):103-13, ix. doi: 10.1016/j.rdc.2004.09.001.Rheum Dis Clin North Am. 2005.PMID:15639058Review.
- Leukocytes in the regulation of pain and analgesia.Rittner HL, Machelska H, Stein C.Rittner HL, et al.J Leukoc Biol. 2005 Dec;78(6):1215-22. doi: 10.1189/jlb.0405223. Epub 2005 Oct 4.J Leukoc Biol. 2005.PMID:16204636Review.
Cited by
- Molecular mechanism for opioid dichotomy: bidirectional effect of μ-opioid receptors on P2X₃ receptor currents in rat sensory neurones.Chizhmakov I, Kulyk V, Khasabova I, Khasabov S, Simone D, Bakalkin G, Gordienko D, Verkhratsky A, Krishtal O.Chizhmakov I, et al.Purinergic Signal. 2015 Jun;11(2):171-81. doi: 10.1007/s11302-015-9443-x. Epub 2015 Jan 16.Purinergic Signal. 2015.PMID:25592684Free PMC article.
- Epigenetics and Pain: New Insights to an Old Problem.Nirvanie-Persaud L, Millis RM.Nirvanie-Persaud L, et al.Cureus. 2022 Sep 20;14(9):e29353. doi: 10.7759/cureus.29353. eCollection 2022 Sep.Cureus. 2022.PMID:36159345Free PMC article.Review.
- Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.Kim BS, Inan S, Ständer S, Sciascia T, Szepietowski JC, Yosipovitch G.Kim BS, et al.Exp Dermatol. 2022 Dec;31(12):1900-1907. doi: 10.1111/exd.14669. Epub 2022 Sep 23.Exp Dermatol. 2022.PMID:36054458Free PMC article.
- Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.Kocot-Kępska M, Zajączkowska R, Mika J, Kopsky DJ, Wordliczek J, Dobrogowski J, Przeklasa-Muszyńska A.Kocot-Kępska M, et al.Pharmaceutics. 2021 Mar 26;13(4):450. doi: 10.3390/pharmaceutics13040450.Pharmaceutics. 2021.PMID:33810493Free PMC article.Review.
- Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine.Machado FC, Zambelli VO, Fernandes AC, Heimann AS, Cury Y, Picolo G.Machado FC, et al.Br J Pharmacol. 2014 Feb;171(4):961-72. doi: 10.1111/bph.12488.Br J Pharmacol. 2014.PMID:24460677Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials